Patterns of contraceptive use through later reproductive years: A cohort study of Australian women with chronic disease.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
05
2022
accepted:
11
04
2023
medline:
5
5
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
epublish
Résumé
Pregnancies among women with chronic disease are associated with poor maternal and fetal outcomes. There is a need to understand how women use or don't use contraception across their reproductive years to better inform the development of preconception care strategies to reduce high risk unintended pregnancies, including among women of older reproductive age. However, there is a lack of high-quality longitudinal evidence to inform such strategies. We examined patterns of contraceptive use among a population-based cohort of reproductive aged women and investigated how chronic disease influenced contraceptive use over time. Contraceptive patterns from 8,030 women of reproductive age from the Australian Longitudinal Study on Women's Health (1973-78 cohort), who were at potential risk of an unintended pregnancy were identified using latent transition analysis. Multinomial mixed-effect logistic regression models were used to evaluate the relationship between contraceptive combinations and chronic disease. Contraception non-use increased between 2006 and 2018 but was similar between women with and without chronic disease (13.6% vs. 12.7% among women aged 40-45 years in 2018). When specific contraceptive use patterns were examined over time, differences were found for women with autoinflammatory diseases only. These women had increased odds of using condom and natural methods (OR = 1.20, 95% CI = 1.00, 1.44), and sterilisation and other methods (OR = 1.61, 95% CI = 1.08, 2.39) or no contraception (OR = 1.32, 95% CI = 1.04, 1.66), compared to women without chronic disease using short-acting methods and condoms. Potential gaps in the provision of appropriate contraceptive access and care exist for women with chronic disease, particularly for women diagnosed with autoinflammatory conditions. Development of national guidelines as well as a clear coordinated contraceptive strategy that begins in adolescence and is regularly reviewed during care management through their main reproductive years and into perimenopause is required to increase support for, and agency among, women with chronic disease.
Sections du résumé
BACKGROUND
Pregnancies among women with chronic disease are associated with poor maternal and fetal outcomes. There is a need to understand how women use or don't use contraception across their reproductive years to better inform the development of preconception care strategies to reduce high risk unintended pregnancies, including among women of older reproductive age. However, there is a lack of high-quality longitudinal evidence to inform such strategies. We examined patterns of contraceptive use among a population-based cohort of reproductive aged women and investigated how chronic disease influenced contraceptive use over time.
METHODS AND FINDINGS
Contraceptive patterns from 8,030 women of reproductive age from the Australian Longitudinal Study on Women's Health (1973-78 cohort), who were at potential risk of an unintended pregnancy were identified using latent transition analysis. Multinomial mixed-effect logistic regression models were used to evaluate the relationship between contraceptive combinations and chronic disease. Contraception non-use increased between 2006 and 2018 but was similar between women with and without chronic disease (13.6% vs. 12.7% among women aged 40-45 years in 2018). When specific contraceptive use patterns were examined over time, differences were found for women with autoinflammatory diseases only. These women had increased odds of using condom and natural methods (OR = 1.20, 95% CI = 1.00, 1.44), and sterilisation and other methods (OR = 1.61, 95% CI = 1.08, 2.39) or no contraception (OR = 1.32, 95% CI = 1.04, 1.66), compared to women without chronic disease using short-acting methods and condoms.
CONCLUSION
Potential gaps in the provision of appropriate contraceptive access and care exist for women with chronic disease, particularly for women diagnosed with autoinflammatory conditions. Development of national guidelines as well as a clear coordinated contraceptive strategy that begins in adolescence and is regularly reviewed during care management through their main reproductive years and into perimenopause is required to increase support for, and agency among, women with chronic disease.
Identifiants
pubmed: 37134070
doi: 10.1371/journal.pone.0268872
pii: PONE-D-22-13508
pmc: PMC10155986
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0268872Informations de copyright
Copyright: © 2023 Harris et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Crohns Colitis. 2014 Jun;8(6):469-79
pubmed: 24183231
Mult Scler. 2014 Apr;20(5):527-36
pubmed: 24446387
Perspect Sex Reprod Health. 2020 Sep;52(3):181-190
pubmed: 33191577
J Womens Health (Larchmt). 2016 Dec;25(12):1262-1269
pubmed: 27295335
Gut. 2007 Jun;56(6):830-7
pubmed: 17185356
Clin Rheumatol. 2019 Apr;38(4):1207-1212
pubmed: 30649682
J Autoimmun. 2017 May;79:17-27
pubmed: 28256367
PLoS One. 2021 Aug 11;16(8):e0255913
pubmed: 34379661
Int J Rheum Dis. 2014 Jul;17(6):653-7
pubmed: 24673794
N Z Med J. 2019 Jul 26;132(1499):11-17
pubmed: 31352469
Med J Aust. 2018 Nov 5;209(9):407-408
pubmed: 30282564
Womens Health Issues. 2005 Jul-Aug;15(4):167-73
pubmed: 16051107
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
BMC Health Serv Res. 2013 Jan 31;13:36
pubmed: 23368720
Contraception. 2013 Aug;88(2):263-8
pubmed: 23245354
PLoS One. 2021 Aug 18;16(8):e0254668
pubmed: 34407075
Perspect Sex Reprod Health. 2015 Sep;47(3):131-9
pubmed: 26287965
Contraception. 2014 May;89(5):419-25
pubmed: 24486008
Contraception. 2010 Jul;82(1):72-85
pubmed: 20682145
BMJ. 2006 Jul 22;333(7560):177
pubmed: 16782722
Arthritis Care Res (Hoboken). 2011 Mar;63(3):358-65
pubmed: 21080446
Contraception. 2016 Nov;94(5):548-555
pubmed: 27373543
Best Pract Res Clin Obstet Gynaecol. 2009 Apr;23(2):199-209
pubmed: 19223239
Contraception. 2011 Jul;84(1):57-63
pubmed: 21664511
Am J Public Health. 2014 Feb;104 Suppl 1:S43-8
pubmed: 24354819
Obstet Gynecol. 2014 Jun;123(6):1213-1220
pubmed: 24807345
Arthritis Care Res (Hoboken). 2018 Feb;70(2):169-174
pubmed: 28437837
Circulation. 2006 Jan 31;113(4):517-24
pubmed: 16449731
Aust Fam Physician. 2017 Jun;46(6):372-377
pubmed: 28609592
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1132-1140
pubmed: 30106516
Fam Pract. 2013 Feb;30(1):64-8
pubmed: 22843639
Reprod Health. 2022 May 7;19(1):111
pubmed: 35525995
Int J Epidemiol. 2015 Oct;44(5):1547,1547a-1547f
pubmed: 26130741
J Obstet Gynaecol. 2018 Oct;38(7):975-978
pubmed: 29553849
Contraception. 2016 Dec;94(6):713-724
pubmed: 27343750
Matern Child Health J. 2018 Jun;22(6):830-840
pubmed: 29411252
Contraception. 2010 Jul;82(1):64-71
pubmed: 20682144